Glyoka-M1 Forte Tablet PR
Glyoka-M1 Forte Tablet PR
Glimepiride (1mg) + Metformin (1000mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Glyoka-M1 Forte Tablet PR is a fixed-dose combination medication containing Glimepiride 1mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to reduced blood glucose levels. This combination offers complementary mechanisms of action that effectively lower fasting and postprandial blood glucose. Glyoka-M1 Forte Tablet PR is intended for patients inadequately controlled on diet and exercise alone or those requiring additional glycemic control beyond monotherapy. The prolonged-release formulation ensures a steady plasma concentration, minimizing gastrointestinal side effects commonly associated with metformin immediate-release formulations. It is essential to monitor renal function prior to and during therapy due to the risk of lactic acidosis associated with metformin. Caution is advised in patients with hepatic impairment, cardiovascular disease, or conditions predisposing to hypoxia. Regular monitoring of blood glucose and HbA1c levels is recommended to assess therapeutic efficacy and adjust dosage accordingly. Glyoka-M1 Forte Tablet PR should be used as part of a comprehensive diabetes management plan including diet, exercise, and lifestyle modifications.
Active composition
Glimepiride 1 mg
+1 more active ingredient
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glyoka-M1 Forte Tablet PR.
High Risk
Pregnancy
Glyoka-M1 Forte Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glyoka-M1 Forte Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glyoka-M1 Forte Tablet PR may be needed. Please consult your doctor. Glyoka-M1 Forte Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glyoka-M1 Forte Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Glyoka-M1 Forte Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glyoka-M1 Forte Tablet PR may be needed. Please consult your doctor. Use of Glyoka-M1 Forte Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Glyoka-M1 Forte Tablet PR
